<DOC>
	<DOCNO>NCT02781857</DOCNO>
	<brief_summary>To answer question whether disease specific profile breath patient lung cancer detect untargeted metabolomic study use exhale breath analysis mass spectrometry .</brief_summary>
	<brief_title>Mass Spectral Fingerprinting Lung Cancer</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<criteria>Confirmed lung cancer base cytological histological analysis . Group A : squamous cell carcinoma amenable surgical resection ( TNM stage IIIa ) . Group B : type lung cancer ( smallcell carcinoma , nonsmallcell carcinoma ) amenable surgical resection . Group C : healthy control . Age 18 85 year study entry Another 'active ' secondary malignant disease ( e.g . breast cancer , colon carcinoma ) group A B , presence active malignant disease group C ( base personal information ) . Acute inflammatory disease ( e.g . common cold ) within last 4 week . Any chronic lung disease chronic obstructive lung disease ( COPD ) . Acute chronic hepatic disease . Renal failure renal replacement therapy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Exhaled Breath</keyword>
	<keyword>Mass Spectrometry</keyword>
	<keyword>Fingerprinting</keyword>
</DOC>